Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
Clinical trial NCT02477878 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02477878
- Sponsor
- Bellicum Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2020-01-14
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.